20 (AIDX) Leases (2024 - 2026)
20 posted quarterly Leases of $562507.0 for Q1 2026, down 7.07% on a QoQ basis from $605289.0 in Q4 2025.
20 (AIDX) has 3 years of Leases data on file, last reported at $562507.0 in Q1 2026.
- For the quarter ending Q1 2026, Leases changed N/A year-over-year to $562507.0; the trailing twelve-month figure through Mar 2026 stood at $562507.0 (changed N/A YoY), and the FY2025 full-year result was $605289.0, down 21.63% from the prior year.
- Leases for Q1 2026 stood at $562507.0, down from $605289.0 in the prior quarter.
- Across five years, Leases topped out at $772385.0 in Q4 2024 and bottomed at $562507.0 in Q1 2026.
- The 3-year median for Leases is $605289.0 (2025), against an average of $646727.0.
- Peak annual rise in Leases reached 21.63% in 2025, while the deepest fall reached 21.63% in 2025.
- A 3-year view of Leases shows it stood at $772385.0 in 2024, then declined by 21.63% to $605289.0 in 2025, then dropped by 7.07% to $562507.0 in 2026.
- The last three Leases figures came in at $562507.0 (Q1 2026), $605289.0 (Q4 2025), and $772385.0 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 547.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 99.30 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 73.10 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 396.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 155.20 Mn |
| 10 | 20 | - | - | 62,884.00 | 562,507.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 562,507.00 |
| Dec 31, 2025 | 605,289.00 |
| Dec 31, 2024 | 772,385.00 |